SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-003708
Filing Date
2018-05-02
Accepted
2018-05-02 09:05:36
Documents
42
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20180331x10q.htm 10-Q 925301
2 EX-31.1 mrns-20180331ex311146b30.htm EX-31.1 15223
3 EX-31.2 mrns-20180331ex312d77eab.htm EX-31.2 15366
4 EX-32.1 mrns-20180331ex321582820.htm EX-32.1 9441
5 GRAPHIC mrns20180331x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-18-003708.txt   2694851

Data Files

Seq Description Document Type Size
6 EX-101.INS mrns-20180331.xml EX-101.INS 406706
7 EX-101.SCH mrns-20180331.xsd EX-101.SCH 17950
8 EX-101.CAL mrns-20180331_cal.xml EX-101.CAL 27676
9 EX-101.DEF mrns-20180331_def.xml EX-101.DEF 56520
10 EX-101.LAB mrns-20180331_lab.xml EX-101.LAB 202715
11 EX-101.PRE mrns-20180331_pre.xml EX-101.PRE 134665
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 18797726
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences